All Stories

  1. Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey

    Article • Current Medical Research and Opinion, February 2019, Taylor & Francis

    Scott Flanders

  2. Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research

    Article • Future Oncology, December 2016, Future Medicine

    Scott Flanders, david penson

  3. Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer

    Article • Journal of Medical Economics, September 2016, Taylor & Francis

    Scott Flanders

  4. MP73-13 BUDGET IMPACT ANALYSIS OF ENZALUTAMIDE FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER FROM A US PAYER PERSPECTIVE

    Article • The Journal of Urology, April 2015, Elsevier

    Scott Flanders

  5. Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999–2003

    Article • Journal of Child and Adolescent Psychopharmacology, June 2007, Mary Ann Liebert Inc

    Scott Flanders

  6. Direct Health Care Costs for Children with Pervasive Developmental Disorders: 1996–2002

    Article • Administration and Policy in Mental Health and Mental Health Services Research, November 2006, Springer Science + Business Media

    Scott Flanders

  7. HEALTH RELATED QUALITY OF LIFE DIFFERENCES BETWEEN BLACK AND WHITE MEN WITH PROSTATE CANCER:

    Article • The Journal of Urology, December 2001, Elsevier

    Scott Flanders

  8. HEALTH RELATED QUALITY OF LIFE DIFFERENCES BETWEEN BLACK AND WHITE MEN WITH PROSTATE CANCER: DATA FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR

    Article • The Journal of Urology, December 2001, Elsevier

    Scott Flanders

  9. PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASES

    Article • The Journal of Urology, October 2001, Elsevier

    Scott Flanders

  10. PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASES

    Article • The Journal of Urology, October 2001, Elsevier

    Scott Flanders

  11. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer

    Article • Journal of Clinical Epidemiology, April 2001, Elsevier

    Scott Flanders

  12. QUALITY OF LIFE BEFORE DEATH FOR MEN WITH PROSTATE CANCER: RESULTS FROM THE CaPSURE DATABASE

    Article • The Journal of Urology, March 2001, Elsevier

    Scott Flanders

  13. QUALITY OF LIFE BEFORE DEATH FOR MEN WITH PROSTATE CANCER: RESULTS FROM THE CaPSURE DATABASE

    Article • The Journal of Urology, March 2001, Elsevier

    Scott Flanders

  14. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CaPSURE database

    Article • Urology, March 2001, Elsevier

    Scott Flanders

  15. UNDER STAGING AND UNDER GRADING IN A CONTEMPORARY SERIES OF PATIENTS UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASE

    Article • The Journal of Urology, March 2001, Elsevier

    Scott Flanders

  16. UNDER STAGING AND UNDER GRADING IN A CONTEMPORARY SERIES OF PATIENTS UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASE

    Article • The Journal of Urology, March 2001, Elsevier

    Scott Flanders

  17. URINARY FUNCTION AND BOTHER AFTER RADICAL PROSTATECTOMY OR RADIATION FOR PROSTATE CANCER:

    Article • The Journal of Urology, December 2000, Elsevier

    Scott Flanders

  18. URINARY FUNCTION AND BOTHER AFTER RADICAL PROSTATECTOMY OR RADIATION FOR PROSTATE CANCER:: A LONGITUDINAL, MULTIVARIATE QUALITY OF LIFE ANALYSIS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR

    Article • The Journal of Urology, December 2000, Elsevier

    Scott Flanders

  19. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CaPSURE database

    Article • Urology, September 2000, Elsevier

    Scott Flanders

  20. PATTERNS OF TREATMENT OF PATIENTS WITH PROSTATE CANCER INITIALLY MANAGED WITH SURVEILLANCE: RESULTS FROM THE CaPSURE DATABASE

    Article • The Journal of Urology, July 2000, Elsevier

    Scott Flanders

  21. PATTERNS OF TREATMENT OF PATIENTS WITH PROSTATE CANCER INITIALLY MANAGED WITH SURVEILLANCE: RESULTS FROM THE CaPSURE DATABASE

    Article • The Journal of Urology, July 2000, Elsevier

    Scott Flanders

  22. IMPACT OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER RECURRENCE AND THE USE OF SECONDARY CANCER TREATMENT:

    Article • The Journal of Urology, April 2000, Elsevier

    Scott Flanders

  23. IMPACT OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER RECURRENCE AND THE USE OF SECONDARY CANCER TREATMENT: DATA FROM THE CAPSURE DATABASE

    Article • The Journal of Urology, April 2000, Elsevier

    Scott Flanders

  24. Q3: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN AFRICAN AMERICAN MEN WITH PROSTATE CANCER: DATA FROM CaPSURE

    Article • Value in Health, March 2000, Elsevier

    Scott Flanders

  25. PMW1: THE NEED FOR A QUALITY-OF-LIFE INSTRUMENT FOR ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW OF THE LITERATURE

    Article • Value in Health, March 2000, Elsevier

    Scott Flanders

  26. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE

    Article • Urology, September 1999, Elsevier

    Scott Flanders

  27. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer

    Article • Urology, September 1999, Elsevier

    Scott Flanders

  28. PCD9: UTILIZATION OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) TREATMENTS AMONG PROSTATE CANCER PATIENTS IN CaPSURE

    Article • Value in Health, May 1999, Elsevier

    Scott Flanders

  29. PCD10: DIFFERENCES IN END-OF-LIFE MEDICAL CARE COSTS FOR PROSTATE CANCER PATIENTS: RESULTS FROM THE CaPSURE DATABASE

    Article • Value in Health, May 1999, Elsevier

    Scott Flanders

  30. Utilization and costs of medical care for prostate cancer patients in the year prior to death

    Article • The Journal of Urology, April 1999, Elsevier

    Scott Flanders

  31. INSURANCE STATUS AFFECTS QUALITY OF LIFE OUTCOMES IN MEN WITH PROSTATE CANCER

    Article • The Journal of Urology, April 1999, Elsevier

    Scott Flanders

  32. PATTERNS OF TREATMENT IN PATIENTS WITH PROSTATE CANCER INITIALLY MANAGED WITH SURVEILLANCE

    Article • The Journal of Urology, April 1999, Elsevier

    Scott Flanders

  33. FIRST-YEAR COSTS OF TREATING PROSTATE CANCER DIAGNOSED AT DIFFERENT STAGES

    Article • The Journal of Urology, April 1999, Elsevier

    Scott Flanders

  34. Approaches to Missing Data Inference Results from CaPSURE

    Article • PharmacoEconomics, January 1999, Springer Science + Business Media

    Scott Flanders

  35. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE

    Article • Urology, January 1999, Elsevier

    Scott Flanders

  36. USE OF IMAGING TESTS FOR STAGING NEWLY DIAGNOSED PROSTATE CANCER

    Article • The Journal of Urology, December 1998, Elsevier

    Scott Flanders

  37. USE OF IMAGING TESTS FOR STAGING NEWLY DIAGNOSED PROSTATE CANCER: TRENDS FROM THE CAPSURE DATABASE

    Article • The Journal of Urology, December 1998, Elsevier

    Scott Flanders

  38. USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER

    Article • The Journal of Urology, October 1998, Elsevier

    Scott Flanders

  39. USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER: DATA FROM THE caPSURE DATABASE

    Article • The Journal of Urology, October 1998, Elsevier

    Scott Flanders

  40. PMD10 The Development of A Patient Outcomes Software for Urologists: Capsure POS™

    Article • Value in Health, May 1998, Elsevier

    Scott Flanders

  41. MHB5 Changes in Sexual Function And Bother in Men Treated for Prostate Cancer: Results from the Capsure™ Database

    Article • Value in Health, May 1998, Elsevier

    Scott Flanders

  42. The capsure database: a methodology for clinical practice and research in prostate cancer

    Article • Urology, November 1996, Elsevier

    Scott Flanders